Erectile Dysfunction Drugs Market Product Overview, Share by Types and Region till 2022
The Erectile Dysfunction Drugs Market report provides a detailed evaluation of the industry by highlighting information on different aspects which include drivers, restraints, growth opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. It also provides a detailed analysis of global market size, regional and country-level market size, competitive landscape, impact of domestic market players and value chain optimization. Furthermore, it sheds light on the market contribution, recent developments and successful marketing strategies of leading companies.
Market Insights
The global Erectile Dysfunction Drugs Market size is expected to value at USD 3.2 billion by 2022. The market is subject to witness a substantial growth due to the rising health awareness among general population and increase in initiatives undertaken by local governments and private bodies to promote use of erectile dysfunction drugs. Growing education levels about use of these products coupled with rising geriatric population base across the globe is predicted to drive the growth of erectile dysfunction drugs industry over the forecast period. Changing food habits and adoption of sedentary lifestyle has led to prevalence of lifestyle diseases, thus propelling the demand for erectile dysfunction drugs in the market.
Request a Sample Copy
of Erectile Dysfunction Drugs Market Report @ https://www.millioninsights.com/industry-reports/erectile-dysfunction-drugs-market/request-sample
Development of various
molecule combinations and drug delivery techniques like creams and pellets to
achieve higher efficacy and performance are predicted to fuel market demand for
the erectile dysfunction drugs, in the upcoming period. Globally, the erectile
dysfunction drug market is predicted to grow at a higher CAGR over the forecast
period, providing numerous opportunities for market players to invest in
research and development of the erectile dysfunction drugs industry. Additionally,
the rise in number of the patents for key drug molecules and higher approval
rate by regional & international authorities are expected to stimulate the
market growth over the forecast period.
However, the patent
expiration of key drugs molecules and lack of awareness in the rural areas,
particularly in the Asia Pacific region is expected to limit market growth to a
certain extent. Furthermore, health hazards due to excessive use of the
erectile dysfunction drugs are restraining overall market growth, in the recent
years.
Low cost counterfeit
drugs and easy availability are leading to decline in the valuation of the
branded erectile dysfunction drugs. Yet, growing research & development
activities and various regional government reforms couple with public awareness
initiatives in various parts of the globe are projected to foster market
expansion in the upcoming period. In addition, rising healthcare infrastructure
activities, strong economic growth, and rising target population are
anticipated to offer lucrative market opportunities for existing market players
in the region.
Erectile Dysfunction Drugs Product Outlook (Revenue, USD Million, 2012 -
2022)
• Viagra (sildenafil citrate)
• Cialis (tadalafil)
• Levitra/Staxyn (vardenafil)
• Stendra/Spedra (avanafil)
• Zydena (udenafil)
• Vitaros (Alprostadil Cream)
• Others
Key Players Analysis covered in these report
• Apricus Biosciences Incorporations
• Bayer
• Cristalia Dong-A Pharmaceutical Co.
• Produtos Quimicos Farmaceuticos
• Meda Pharmaceuticals Incorporations and
many others
Access Erectile
Dysfunction Drugs Market Report with TOC @ https://www.millioninsights.com/industry-reports/erectile-dysfunction-drugs-market
The erectile dysfunction
drug industry is divided by region as North America, Europe, Asia-Pacific,
Latin America and Africa. North America has shown major growth in recent years
owing to the rise in the implementation of latest technologies in medicine
& pharmaceutical sector, increase in the approval rate, rising research
& development initiatives regarding the development of innovative drug
molecules and existence of well-established healthcare infrastructure in the
region.
Comments
Post a Comment